165 related articles for article (PubMed ID: 3470578)
1. In-vitro studies on phosphorylation and dephosphorylation of cytosine arabinoside in human leukemic cells.
Muus P; Drenthe-Schonk A; Haanen C; Wessels H; Linssen P
Leuk Res; 1987; 11(4):319-25. PubMed ID: 3470578
[TBL] [Abstract][Full Text] [Related]
2. [Intracellular retention of cytarabine-triphosphate (Ara-CTP) in blasts of children with acute lymphoblastic leukemia. Correlation with clinical course parameters].
Schiller M; Hohenlöchter B; Schulze-Westhoff P; Zimmermann M; Ritter J; Jürgens H; Boos J
Klin Padiatr; 1996; 208(4):151-9. PubMed ID: 8926681
[TBL] [Abstract][Full Text] [Related]
3. Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow.
Tanaka M
Leuk Res; 1993 Jul; 17(7):585-92. PubMed ID: 8326741
[TBL] [Abstract][Full Text] [Related]
4. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia.
Boos J; Hohenlöchter B; Schulze-Westhoff P; Schiller M; Zimmermann M; Creutzig U; Ritter J; Jurgens H
Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376
[TBL] [Abstract][Full Text] [Related]
5. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity.
Tanaka M; Yoshida S
Jpn J Cancer Res; 1987 Aug; 78(8):851-7. PubMed ID: 3115933
[TBL] [Abstract][Full Text] [Related]
6. On the interaction between cytosine arabinoside and etoposide in vivo and in vitro.
Liliemark J; Knochenhauer E; Gruber A; Pettersson B; Björkholm M; Peterson C
Eur J Haematol; 1993 Jan; 50(1):22-5. PubMed ID: 8436210
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of interleukin 3 on the metabolism of high-dose cytosine arabinoside in normal versus leukemic human bone marrow cells.
Bhalla K; Birkhofer M; Arlin Z; Grant S; Lutzky J; Safah H; Graham G
Exp Hematol; 1991 Aug; 19(7):669-73. PubMed ID: 1893953
[TBL] [Abstract][Full Text] [Related]
8. Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines.
Noordhuis P; Kazemier KM; Kasperrs GJ; Peters GJ
Leuk Res; 1996 Feb; 20(2):127-34. PubMed ID: 8628011
[TBL] [Abstract][Full Text] [Related]
9. Variations of the phosphorylation of 1-beta-D-arabinofuranosylcytosine (ARA-C) in human myeloid leukemic cells related to the cell cycle.
Vierwinden G; Drenthe-Schonk AM; Plas AM; Linssen PC; Pennings AH; Holdrinet RS; van Egmond J; Wessels JM; Haanen CA
Leuk Res; 1982; 6(2):251-9. PubMed ID: 6964370
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells.
Bhalla K; Birkhofer M; Arlin Z; Grant S; Lutzky J; Graham G
Leukemia; 1988 Dec; 2(12):810-3. PubMed ID: 3264363
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
Hiddemann W; Kiehl M; Zühlsdorf M; Busemann C; Schleyer E; Wörmann B; Büchner T
Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the cellular pharmacokinetics of ara-CTP in human leukemic blasts by dipyridamole.
Yang JL; White JC; Capizzi RL
Cancer Chemother Pharmacol; 1992; 29(3):236-40. PubMed ID: 1733557
[TBL] [Abstract][Full Text] [Related]
13. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
Plunkett W; Liliemark JO; Adams TM; Nowak B; Estey E; Kantarjian H; Keating MJ
Cancer Res; 1987 Jun; 47(11):3005-11. PubMed ID: 3471322
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.
Plunkett W; Hug V; Keating MJ; Chubb S
Cancer Res; 1980 Mar; 40(3):588-91. PubMed ID: 6937239
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of arabinosyluracil 5'-triphosphate during arabinosylcytosine therapy in circulating blasts of patients with acute myelogenous leukemia.
Gandhi V; Xu YZ; Estey E
Clin Cancer Res; 1998 Jul; 4(7):1719-26. PubMed ID: 9676847
[TBL] [Abstract][Full Text] [Related]
16. [Relation between plasma Ara-C and intracellular Ara-CTP levels by intermediate dose and high dose Ara-C administration in the treatment of AML].
Yoshida T; Kobayashi K; Nakamura S; Ohtake S; Itoh K; Kanno M; Hirai J; Yasushi ; Matsuda TT
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):625-30. PubMed ID: 3162669
[TBL] [Abstract][Full Text] [Related]
17. Efficient formation of cytosine arabinoside-5'-triphosphate in leukemic blasts of human T-cell acute lymphoblastic leukemia.
Tanaka M; Yoshida S
Leuk Res; 1989; 13(10):931-6. PubMed ID: 2586146
[TBL] [Abstract][Full Text] [Related]
18. Intracellular cytosine arabinoside accumulation and cytosine arabinoside triphosphate formation in leukemic blast cells is inhibited by etoposide and teniposide.
Ehninger G; Proksch B; Wanner T; Schuler U; Busch FW; Schmidt H; Schleyer E; Jaschonek K; Hiddemann W
Leukemia; 1992 Jun; 6(6):582-7. PubMed ID: 1602795
[TBL] [Abstract][Full Text] [Related]
19. Calculation of individual dosage regimen of cytosine arabinoside (ara-C) based on metabolite levels in leukemic cells.
Riva-Lavieille C; Ressayre C; Barra Y; Carcassonne Y; Iliadis A
Ther Drug Monit; 1994 Aug; 16(4):375-9. PubMed ID: 7974627
[TBL] [Abstract][Full Text] [Related]
20. Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells.
Momparler RL; Onetto-Pothier N; Bouffard DY; Momparler LF
Cancer Chemother Pharmacol; 1990; 27(2):141-6. PubMed ID: 2249330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
